Philips Receives FDA Approval for AI-based Cardiac Surgery Tool
Royal Philips announced in a press release that it has received FDA approval for EchoNavigator R5.0 with DeviceGuide, an artificial intelligence-based software solution designed to assist physicians during complex minimally invasive cardiac valve repair procedures.
Innovative Integration of AI in Cardiac Procedures
DeviceGuide utilizes artificial intelligence to track and visualize mitral valve repair devices in real-time during minimally invasive procedures. The solution is integrated into Philips' Azurion guided imaging platform, which combines imaging, real-time data, and intelligent software into a unified workflow, enabling more consistent, efficient, and confidently performed minimally invasive interventions.
FDA Approval Amid Technically Demanding Cardiology Procedures
This FDA approval comes in the context of some of the most technically demanding procedures in interventional cardiology. Philips positions this solution as a support tool for physicians, aligning with its broader strategy in the healthcare and guided imaging technology sectors.
